Congress / Off-Label Prescribing Among Office / office of Inspector General / Food and Drug Administration / US Federal Reserve / Department of Veterans Affairs Health Care System / Department of Veterans Affairs / Department of Health and Human Services / Department of Health / Department of Justice / AGENCY COMMENTS AND OFFICE OF INSPECTOR GENERAL RESPONSE In / Agency for Healthcare Research and Quality / MEDICARE / /
Person
Charles Grassley / Response / MEDICARE ATYPICAL ANTIPSYCHOTIC / LY NU / /
Position
ELDERLY NURSING HOME RESIDENTS Daniel R. Levinson Inspector General / EXECUTIVE / consultant / /
Product
Appendix A. Off-Label Drug / Olanzapine / Fluoxetine / Clozapine / Approved Atypical Antipsychotic / Risperdal / Risperidone / drugs / If drug / approved / FDA Drug / atypical / /
PublishedMedium
the Archives of Internal Medicine / Archives of Internal Medicine / /